28508329|t|Long Non-Coding RNA SNHG6 as a Potential Biomarker for Hepatocellular Carcinoma
28508329|a|Long Non-coding RNAs (lncRNAs) refer to all non-protein coding transcripts longer than 200 nucleotides. Their critical roles in different biological pathways have been already well established. Altered expression of lncRNAs can be involved in the cancer initiation and/or progression. Since patients with hepatocellular carcinoma (HCC) are usually diagnosed in late stages, developing diagnostic methods seems to be essential. In this study, the expression levels of different lncRNAs were systematically analysed in different genomic and transcriptome datasets. The analyses showed that SNHG6 is among the lncRNAs with distinctive dysregulation of expression and copy number variation in HCC tumors compared with normal tissues. The results also suggest that the dysregulation of SNHG6 is highly cancer type specific. Through co-occurrence analyses, we found that SNHG6 and its related co-expressed genes on 8q are involved in the structural integrity of ribosome and translation. This comprehensive in silico analysis, provides a resource for investigating SNHG6 in hepatocellular carcinoma and lays the groundwork for design of next researches.
28508329	0	19	Long Non-Coding RNA	T114,T123	C3494264
28508329	20	25	SNHG6	T028	C1822801
28508329	41	50	Biomarker	T123	C0041365
28508329	55	79	Hepatocellular Carcinoma	T191	C2239176
28508329	80	100	Long Non-coding RNAs	T114,T123	C3494264
28508329	102	109	lncRNAs	T114,T123	C3494264
28508329	124	142	non-protein coding	T114	C0887909
28508329	143	154	transcripts	T114	C1519595
28508329	171	182	nucleotides	T114	C0028630
28508329	218	228	biological	T080	C0205460
28508329	229	237	pathways	T077	C1705987
28508329	282	292	expression	T045	C0017262
28508329	296	303	lncRNAs	T114,T123	C3494264
28508329	327	344	cancer initiation	T191	C0598935
28508329	352	363	progression	T191	C0178874
28508329	371	379	patients	T101	C0030705
28508329	385	409	hepatocellular carcinoma	T191	C2239176
28508329	411	414	HCC	T191	C2239176
28508329	428	437	diagnosed	T033	C0011900
28508329	441	452	late stages	T079	C1279941
28508329	465	483	diagnostic methods	T060	C0920688
28508329	515	520	study	T062	C2603343
28508329	526	536	expression	T045	C0017262
28508329	557	564	lncRNAs	T114,T123	C3494264
28508329	585	593	analysed	T062	C0936012
28508329	607	614	genomic	T170	C0150098
28508329	619	641	transcriptome datasets	T170	C0150098
28508329	647	655	analyses	T062	C0936012
28508329	668	673	SNHG6	T028	C1822801
28508329	687	694	lncRNAs	T114,T123	C3494264
28508329	712	725	dysregulation	T045	C0017263
28508329	729	739	expression	T045	C0017262
28508329	769	779	HCC tumors	T191	C2239176
28508329	794	808	normal tissues	T024	C0040300
28508329	844	857	dysregulation	T045	C0017263
28508329	861	866	SNHG6	T028	C1822801
28508329	877	883	cancer	T191	C0006826
28508329	921	929	analyses	T062	C0936012
28508329	945	950	SNHG6	T028	C1822801
28508329	967	979	co-expressed	T045	C0017262
28508329	980	985	genes	T028	C0017337
28508329	989	991	8q	T086	C1515445
28508329	1012	1022	structural	T082	C0678594
28508329	1023	1032	integrity	T080	C1947912
28508329	1036	1044	ribosome	T026	C0035553
28508329	1049	1060	translation	T045	C1519614
28508329	1067	1080	comprehensive	T080	C1880156
28508329	1081	1090	in silico	T066	C3489666
28508329	1091	1099	analysis	T062	C0936012
28508329	1125	1138	investigating	T169	C1292732
28508329	1139	1144	SNHG6	T028	C1822801
28508329	1148	1172	hepatocellular carcinoma	T191	C2239176
28508329	1216	1226	researches	T062	C0035168